Medpace Holdings (NASDAQ: MEDP) reported Q3 EPS of $1.09, $0.02 better than the analyst estimate of $1.07. Revenue for the quarter came in at $230.4 million versus the consensus estimate of $223.56 million.

GUIDANCE:

Medpace Holdings sees FY2020 EPS of $3.62-$3.83, versus the consensus of $3.74. Medpace Holdings sees FY2020 revenue of $888-920 million, versus the consensus of $903 million.

Medpace Holdings sees FY2021 revenue of $1.05-1.125 billion, versus the consensus of $1.11 billion.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.